These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 17152048
21. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S. Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126 [Abstract] [Full Text] [Related]
22. Variability of genetic alterations in different sites of head and neck cancer. Rodrigo JP, Suárez C, González MV, Lazo PS, Ramos S, Coto E, Alvarez I, García LA, Martínez JA. Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558 [Abstract] [Full Text] [Related]
23. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
24. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer. Jie G, Zhixiang S, Lei S, Hesheng L, Xiaojun T. Int J Clin Pract; 2007 Sep 08; 61(9):1523-9. PubMed ID: 17537196 [Abstract] [Full Text] [Related]
25. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck. Wang D, Grecula JC, Gahbauer RA, Schuller DE, Jatana KR, Biancamano JD, Lang JC. Oncol Rep; 2006 Mar 08; 15(3):661-5. PubMed ID: 16465427 [Abstract] [Full Text] [Related]
26. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas. Larque AB, Conde L, Hakim S, Alos L, Jares P, Vilaseca I, Cardesa A, Nadal A. Virchows Arch; 2015 Apr 08; 466(4):375-82. PubMed ID: 25652585 [Abstract] [Full Text] [Related]
27. Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Niméus E, Baldetorp B, Bendahl PO, Rennstam K, Wennerberg J, Akervall J, Fernö M. Oral Oncol; 2004 Jul 08; 40(6):624-9. PubMed ID: 15063391 [Abstract] [Full Text] [Related]
28. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J, Juhász A, Remenár E, Engi H, Bak M, Csuka O, Kásler M. Oncol Rep; 2007 Jul 08; 18(1):105-12. PubMed ID: 17549354 [Abstract] [Full Text] [Related]
29. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, Quattrone P, Locati LD, Bergamini C, Olmi P, Pierotti MA, Pilotti S. J Clin Oncol; 2006 Dec 20; 24(36):5630-6. PubMed ID: 17179101 [Abstract] [Full Text] [Related]
30. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Anticancer Res; 1998 Dec 20; 18(6B):4793-800. PubMed ID: 9891559 [Abstract] [Full Text] [Related]
31. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. Farhadieh RD, Smee R, Rees CG, Salardini A, Eggleton S, Yang JL, Russell PJ. ANZ J Surg; 2009 Dec 20; 79(1-2):48-54. PubMed ID: 19183379 [Abstract] [Full Text] [Related]
32. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Begum S, Gillison ML, Nicol TL, Westra WH. Clin Cancer Res; 2007 Feb 15; 13(4):1186-91. PubMed ID: 17317828 [Abstract] [Full Text] [Related]
33. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Bastide K, Guilly MN, Bernaudin JF, Joubert C, Lectard B, Levalois C, Malfoy B, Chevillard S. Lung Cancer; 2009 Mar 15; 63(3):348-53. PubMed ID: 18656278 [Abstract] [Full Text] [Related]
34. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H, Bosch FX. Oncogene; 1998 Apr 02; 16(13):1671-9. PubMed ID: 9582015 [Abstract] [Full Text] [Related]
35. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM. J Pathol; 2009 Mar 02; 217(4):516-23. PubMed ID: 18991334 [Abstract] [Full Text] [Related]
36. Frequent inactivation of p16INK4a in oral premalignant lesions. Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK, Mao L. Oncogene; 1997 Apr 17; 14(15):1799-803. PubMed ID: 9150385 [Abstract] [Full Text] [Related]
37. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. Eriksen JG, Alsner J, Steiniche T, Overgaard J. Radiother Oncol; 2005 Aug 17; 76(2):135-42. PubMed ID: 16024113 [Abstract] [Full Text] [Related]
38. [The devitalization of tumor suppressor genes in oral squamous cell carcinoma]. Qin X, Guan X, Gao Y, Wang Z, Wang X. Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Dec 17; 18(6):369-70. PubMed ID: 12539460 [Abstract] [Full Text] [Related]
39. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas. Park HW, Song SY, Lee TJ, Jeong D, Lee TY. Oncol Rep; 2007 Jul 17; 18(1):267-72. PubMed ID: 17549378 [Abstract] [Full Text] [Related]
40. beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C, Sanchez-Cespedes M. Cancer Lett; 2005 Dec 08; 230(1):141-8. PubMed ID: 16253770 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]